Biomaterial Database

Adding neonatal hyperbilirubinemia/bilirubin encephalopathy to the American Society for Apheresis Guidelines on Therapeutic Apheresis. 2018

Ryan P Jajosky, and Audrey N Jajosky

Biconcavity Incorporated, 1106 Spring Mill Dr SW, Lilburn, GA, 30047.

UI	MeSH Term	Description	Entries
D007231	Infant, Newborn	An infant during the first 28 days after birth.	Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007647	Kernicterus	A term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER (e.g., SEPSIS). This condition occurs primarily in neonates (INFANT, NEWBORN), but may rarely occur in adults. (Menkes, Textbook of Child Neurology, 5th ed, p613)	Bilirubin Encephalopathy,Hyperbilirubinemic Encephalopathy,Encephalopathy, Bilirubin,Encephalopathy, Hyperbilirubinemic,Bilirubin Encephalopathies,Encephalopathies, Bilirubin,Encephalopathies, Hyperbilirubinemic,Hyperbilirubinemic Encephalopathies
D001781	Blood Component Removal	Any procedure in which blood is withdrawn from a donor, a portion is separated and retained, at the same time the remainder is returned to the donor.	Apheresis,Pheresis,Aphereses,Blood Component Removals,Phereses,Removal, Blood Component
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017410	Practice Guidelines as Topic	Works about directions or principles presenting current or future rules of policy for assisting health care practitioners in patient care decisions regarding diagnosis, therapy, or related clinical circumstances. The guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The guidelines form a basis for the evaluation of all aspects of health care and delivery.	Clinical Guidelines as Topic,Best Practices,Best Practice
D051556	Hyperbilirubinemia, Neonatal	Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated (indirect) or the conjugated (direct) form. The condition may be self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) or pathological with toxic levels of bilirubin.	Neonatal Hyperbilirubinemia,Direct Hyperbilirubinemia, Neonatal,Hyperbilirubinemia During Infancy,Indirect Hyperbilirubinemia, Neonatal,During Infancies, Hyperbilirubinemia,Hyperbilirubinemia, Neonatal Direct,Hyperbilirubinemia, Neonatal Indirect,Infancy, Hyperbilirubinemia During,Neonatal Direct Hyperbilirubinemia,Neonatal Indirect Hyperbilirubinemia